APOE and atherosclerosis: To determine whether HCW9302 can alleviate the progression of atherosclerosis, 6-week-old ApoE deficient mice were fed with WD for 6 weeks after which they were treated with three doses of HCW9302 or PBS control (once every 3 weeks).